LVW Advisors’s BeOne Medicines Ltd. American Depositary Shares ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $247K | Sell |
1,022
-7
| -0.7% | -$1.69K | 0.03% | 287 |
|
|
2025
Q1 | $280K | Sell |
1,029
-103
| -9% | -$28K | 0.03% | 244 |
|
|
2024
Q4 | $209K | Buy |
1,132
+131
| +13% | +$24.2K | 0.03% | 293 |
|
|
2024
Q3 | $225K | Sell |
1,001
-978
| -49% | -$220K | 0.03% | 283 |
|
|
2024
Q2 | $282K | Buy |
1,979
+22
| +1% | +$3.14K | 0.04% | 236 |
|
|
2024
Q1 | $306K | Buy |
1,957
+654
| +50% | +$102K | 0.05% | 228 |
|
|
2023
Q4 | $235K | Sell |
1,303
-188
| -13% | -$33.9K | 0.04% | 234 |
|
|
2023
Q3 | $268K | Sell |
1,491
-313
| -17% | -$56.3K | 0.06% | 182 |
|
|
2023
Q2 | $322K | Sell |
1,804
-15
| -0.8% | -$2.68K | 0.06% | 154 |
|
|
2023
Q1 | $392K | Buy |
1,819
+135
| +8% | +$29.1K | 0.08% | 159 |
|
|
2022
Q4 | $370K | Buy |
1,684
+85
| +5% | +$18.7K | 0.08% | 166 |
|
|
2022
Q3 | $216K | Sell |
1,599
-55
| -3% | -$7.43K | 0.05% | 203 |
|
|
2022
Q2 | $268K | Sell |
1,654
-71
| -4% | -$11.5K | 0.05% | 193 |
|
|
2022
Q1 | $325K | Sell |
1,725
-74
| -4% | -$13.9K | 0.06% | 181 |
|
|
2021
Q4 | $487K | Sell |
1,799
-193
| -10% | -$52.2K | 0.08% | 151 |
|
|
2021
Q3 | $723K | Buy |
1,992
+68
| +4% | +$24.7K | 0.12% | 121 |
|
|
2021
Q2 | $660K | Buy |
1,924
+22
| +1% | +$7.55K | 0.12% | 124 |
|
|
2021
Q1 | $662K | Buy |
1,902
+314
| +20% | +$109K | 0.13% | 119 |
|
|
2020
Q4 | $410K | Buy |
1,588
+351
| +28% | +$90.6K | 0.08% | 136 |
|
|
2020
Q3 | $354K | Buy |
+1,237
| New | +$354K | 0.08% | 137 |
|